Comparison of naproxen with placebo for the management of noncyclical breast pain: a randomized, double-blind, controlled trial.
BACKGROUND
Breast pain is a common symptom in patients attending breast clinics. Although most patients experience mastalgia of mild to moderate severity, approximately 15% of patients suffer from severe pain that causes significant distress and some disturbance in their daily life that lead them to seek treatment. Despite a considerable number of drugs suggested for decreasing the severity of mastalgia, there is no standard treatment for the complaint. In this study, we investigated the effect of naproxen on reducing the complaint of breast pain compared with placebo.


METHODS
Eighty-one women suffering from noncyclic breast pain were recruited to a randomized, double-blind, clinical trial between January 2002 and September 2004. All patients were suffering from this complaint for at least 3 months before the study. Patients were randomly assigned to two groups. Patients in the case group received naproxen 250 mg BD. Patients in the placebo group took placebo in a similar manner. The intensity of mastalgia was assessed before and twice after intervention by using a Visual Analogue Scale.


RESULTS
Forty-two of 81 patients were recruited randomly as cases and the remaining 39 were assigned placebo. Of these 24 and 22 patients fulfilled the study protocol respectively. The mean age of patients was 35 (SD = 7.5; range, 19-55) years. The mean pain severity at the beginning of the study was 5.8 and 6.1 in naproxen and placebo groups, respectively. The severity of pain was decreased significantly at the end of the study in both groups (3.9 in patients and 3.7 in controls (P = 0.005 and 0.0001)). Although the decrease in pain severity in each individual group was statistically significant, it was not significant compared with one another (P = 0.64).


CONCLUSIONS
Breast pain is a complex symptom that can be relieved significantly with reassurance. According to the result of this study, naproxen has no superiority over placebo in reducing noncyclic breast pain.
Kaviani
A
A
Department of Surgery, Imam Hospital, Faculty of Medicine, Tehran University of Medical Sciences, Keshavarz Blvd., Toohid Sq., Tehran, Iran. akaviani@sina.tums.ac.ir
Mehrdad
N
N
Najafi
M
M
Hashemi
E S
ES
Yunesian
M
M
Ebrahimi
M
M
Hooshmand
H
H
Izadi
S
S
D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D001941:Breast Diseases / Q000188:drug therapy* / Q000523:psychology; D004311:Double-Blind Method; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008019:Life Style; D008597:Menstrual Cycle; D009288:Naproxen / Q000627:therapeutic use*; D010146:Pain / Q000188:drug therapy* / Q000523:psychology; D010147:Pain Measurement; D016896:Treatment Outcome
D000894:Anti-Inflammatory Agents, Non-Steroidal; D009288:Naproxen
Mayo Clin Proc. 2004 Mar;79(3):353-72
15008609
Minerva Ginecol. 1992 Oct;44(10):511-4
1461553
Obstet Gynecol Clin North Am. 1994 Sep;21(3):461-77
7816407
Breast J. 2005 Jan-Feb;11(1):41-7
15647077
J Indian Med Assoc. 1997 Jan;95(1):5-8
9212559
Br Med J. 1980 Nov 29;281(6253):1450-3
7437833
J R Coll Surg Edinb. 1998 Jun;43(3):158-9
9654874
Rheumatol Int. 1985;5(4):145-8
4048757
J Reprod Med. 2005 Dec;50(12):933-9
16444894
World J Surg. 1989 Nov-Dec;13(6):699-705
2696222
Breast. 2007 Oct;16(5):503-12
17509880
Breast J. 2000 Nov;6(6):407-409
11348400
N Z Med J. 1998 Feb 13;111(1059):33-4
9506670
Am J Obstet Gynecol. 2002 Nov;187(5):1389-94
12439536
Lancet. 1985 Aug 17;2(8451):373-7
2862523
Drugs. 1993;46 Suppl 1:137-9
7506153
Plast Reconstr Surg. 2005 Sep 15;116(4):978-83; discussion 984-5
16163081
Surgeon. 2005 Feb;3(1):7-10
15789786
Obstet Gynecol Surv. 2002 Jul;57(7):451-61
12172222
J R Soc Med. 1992 Jan;85(1):12-5
1548647
Lancet. 1990 Jan 27;335(8683):190-3
1967667
J Gen Intern Med. 2006 Mar;21 Suppl 3:S70-5
16637950
J Am Coll Surg. 2003 Apr;196(4):525-30
12691925
Am J Obstet Gynecol. 2004 Dec;191(6):1942-9
15592276
Br J Hosp Med. 1990 May;43(5):330-2
2364227
Clin J Pain. 2000 Mar;16(1):22-8
10741815
Curr Med Res Opin. 2004 May;20(5):681-4
15140333